DWTX
Dogwood Therapeutics, Inc.
There isn't enough reported data to score DWTX yet.
DWTX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
DWTX's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
DWTX PE Valuation
DWTX has no meaningful PE right now: it lost money over the past year.
DWTX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect DWTX's losses to shrink, with revenue growing.
DWTX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$26.11 | -$19.56 |
| Q2 2025 | -$19.96 | -$13.96 |
| Q1 2025 | -$19.22 | -$12.47 |
| Q4 2024 | -$12.52 | -$5.52 |
DWTX lost $26.11 per share over the past year, and its loss has widened in each of the last five quarters.
DWTX Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -4917% | N/A |
DWTX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.6M | -$1.4M |
| Q2 2026 | -$3.6M | +$415K |
| Q1 2026 | -$4.6M | +$95.4K |
| Q4 2025 | -$3.6M | +$2.5M |
| Q3 2025 | -$3.3M | -$2.4M |
| Q2 2025 | -$4M | -$3.2M |
| Q1 2025 | -$4.7M | -$3.7M |
| Q4 2024 | -$6.1M | -$4.7M |
DWTX has burned cash in almost every quarter: −$16M over the past year, against −$18M the year before.
DWTX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +8.3K shares |
| 1 year | +110% | +1M shares |
| 3 years | +476% | +1.6M shares |
DWTX has 2M diluted shares, up 110% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
DWTX Net Leverage
DWTX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DWTX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.6 | Neutral |
| Stochastic | 14.5 | Oversold |
DWTX's weekly RSI is 37 (neutral) and its Stochastic is 15 (oversold).
DWTX PE vs Healthcare Sector
DWTX has no meaningful PE right now: it lost money over the past year.
DWTX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.28 | 12% below |
| 20 week MA | $1.63 | 31% below |
| 50 week MA | $2.33 | 52% below |
| 100 week MA | $3.83 | 71% below |
| 200 week MA | $9.42 | 88% below |
DWTX is in a downtrend: it's below all five of its weekly moving averages, and 88% below its 200-week average.
DWTX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $260.0 | $228.5 | -12% |
| 2021 | $228.5 | $140.9 | -38% |
| 2022 | $140.9 | $6.55 | -95% |
| 2023 | $6.55 | $14.4 | +120% |
| 2024 | $14.4 | $2.82 | -80% |
| 2025 | $2.82 | $4.07 | +44% |
| 2026 YTD | $4.07 | $1.12 | -72% |
DWTX's yearly returns have swung widely, from +120% in 2023 to −95% in 2022. It's down 72% so far in 2026.